Dr. Dobbins is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
5 Moore Dr
Research Triangle Park, NC 27709Phone+1 919-483-7922
Education & Training
University of Texas Southwestern Medical CenterFellowship, Endocrinology, Diabetes, and Metabolism, 1996 - 1999- University of Texas Southwestern Medical CenterResidency, Internal Medicine, 1993 - 1996
Vanderbilt University School of MedicineClass of 1991
Certifications & Licensure
TN State Medical License 1996 - 2026
TX State Medical License 1999 - 2025
Publications & Presentations
PubMed
- 143 citationsEffect of ileal bile acid transporter inhibitor GSK2330672 on pruritus in primary biliary cholangitis: a double-blind, randomised, placebo-controlled, crossover, phase...Vinod S. Hegade, Stuart Kendrick, Robert L. Dobbins, Sam R. Miller, Douglas Thompson
Lancet. 2017-03-18 - 29 citationsBAT117213: Ileal bile acid transporter (IBAT) inhibition as a treatment for pruritus in primary biliary cirrhosis: study protocol for a randomised controlled trialVinod S. Hegade, Stuart Kendrick, Robert L. Dobbins, Sam R. Miller, Duncan Richards
BMC Gastroenterology. 2016-07-19 - 12 citationsPharmacokinetics and Pharmacodynamics of the SGLT2 Inhibitor Remogliflozin Etabonate in Subjects with Mild and Moderate Renal ImpairmentRobin L. O'Connor-Semmes, Susan Walker, Anita Kapur, Elizabeth K. Hussey, June Ye
Drug Metabolism and Disposition. 2015-07-01
Other Languages
- Italian
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
